课题基金 / 基金详情

Mitochondrial Thiol Regulation and Programmed Cell Death in Yeast

Mitochondrial Thiol Regulation and Programmed Cell Death in Yeast
酵母中线粒体硫醇调节和程序性细胞死亡
批准号:
BB/J00488X/1
负责人:
Christopher Grant
金额:
$42.1万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2012
资助国家:
英国
项目状态:
已结题
起止时间:
2012 至 --

项目摘要

项目成果

Christopher Grant的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Proteins are key molecules that control most biological processes. Each protein is made-up of a linear polymer of amino acids which adopt a unique three-dimensional structure. It is becoming increasingly recognized that the cysteine amino acid can play a key role in regulating the activity of many different proteins. This is because cysteine amino acids contain a sulphur atom in a thiol group which accounts for its high reactivity in oxidation and reduction reactions. This means that the redox state of cysteine residues in many different proteins, such as enzymes and transcription factors, can profoundly influence their activity. Not surprisingly therefore, alterations in the cellular redox balance are implicated in many disease processes. This work programme will investigate how cells maintain the redox state of mitochondrial proteins. Understanding mitochondrial redox regulation is particularly important since there are many established links between mitochondrial dysfunction and disease. The focus of this project will be on the glutathione/glutaredoxin and thioredoxin systems which constitute the main cellular redox systems. Our preliminary data, described in the application, show that the redox state of the mitochondrial thioredoxin is important for growth and its oxidation induces a form of programmed cell death (PCD). PCD is a normal process in the development of healthy organisms where cells die in a controlled, regulated fashion. It is a form of cell suicide which can be induced in response to a variety of stimuli including stress. It is important because cell death processes have been implicated in numerous disease processes and many medical treatments and interventions act through PCD. We will use the yeast model system to systematically examine and define the cellular concentrations and redox state of the mitochondrial redox regulatory systems. Importantly, we will examine these systems under conditions that induce PCD to determine the regulatory role of the mitochondrial thioredoxin in this process. Genetic approaches will be used to understand how the mitochondrial thioredoxin regulates cell death. A key technique will be to mutate the cysteine residues in the mitochondrial thioredoxin to directly examine their role in regulating PCD, measured using various known markers which act in the cell death pathway. Mitochondria are the main source of reactive oxygen species in most organisms and this is thought to represent a key signal that activates PCD. Thiol groups in proteins are known to be particularly sensitive to oxidation and so the final part of the project we will test the hypothesis that the mitochondrial thioredoxin system acts as a sensor of reactive oxygen species to activate PCD.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.freeradbiomed.2016.02.015
发表时间: 2016-05
期刊: Free radical biology & medicine
影响因子: 7.4
作者: [Gostimskaya I, Grant CM]
通讯作者: Grant CM
Probing the Majorana Nature of Neutrinos with KamLAND-Zen
  • 批准号:
    2310130
  • 项目类别:
    Standard Grant
  • 资助金额:
    $48.0万
  • 财政年份:
    2023
  • 负责人:
    Christopher Grant
  • 依托单位:
Functional specialization of RNP granules in RNA metabolism
  • 批准号:
    BB/W004488/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $97.71万
  • 财政年份:
    2022
  • 负责人:
    Christopher Grant
  • 依托单位:
An Improved Search for Neutrinoless Double Beta Decay with KamLAND-Zen
  • 批准号:
    2012964
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $30.0万
  • 财政年份:
    2020
  • 负责人:
    Christopher Grant
  • 依托单位:
The pathways to prion formation in the response to oxidative stress
  • 批准号:
    BB/S005420/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $52.77万
  • 财政年份:
    2019
  • 负责人:
    Christopher Grant
  • 依托单位:
国内基金
海外基金
基于新型不可逆微管稳定剂TAJ构建基因工程化Thiol-DDR1抗体偶联物靶向治疗结肠癌及其机制研究
  • 批准号:
    82073318
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    王誉熹
  • 依托单位: